Helicobacter pylori targets (H. pylori targets)

Helicobacter pylori targets represent a broad category of bacterial proteins and enzymes essential for the survival, colonization, and virulence of the pathogen within the human stomach. A primary diagnostic and survival target is Urease, which converts urea into ammonia to neutralize gastric acid, creating a habitable microenvironment for the bacteria (StatPearls, 2023). Therapeutic targets include the bacterial protein synthesis machinery (50S and 30S ribosomal subunits), cell wall synthesis enzymes (penicillin-binding proteins), and DNA replication enzymes (DNA gyrase), which are targeted by standard antibiotics like clarithromycin, amoxicillin, and levofloxacin (NIH, 2022). Additionally, H. pylori utilizes specialized virulence factors such as the vacuolating cytotoxin A (VacA) and the cytotoxin-associated gene A (CagA) to disrupt host cell signaling and promote chronic inflammation, which can lead to gastric cancer (PubMed, 2021). Because this entry refers to a collection of distinct molecular entities rather than a single receptor or enzyme, it is classified as a target group. Effective eradication of these targets is the cornerstone of treating peptic ulcers and preventing gastric malignancies, though rising multi-drug resistance poses a significant global health challenge (World Health Organization, 2020).

Other names

H. pylori virulence factorsGastric helicobacter targetsH. pylori proteome targets

Inhibition of the 50S ribosomal subunit (macrolides), inhibition of the 30S ribosomal subunit (tetracyclines), inhibition of cell wall peptidoglycan synthesis (beta-lactams), induction of DNA strand breakage via reductive activation (nitroimidazoles), and inhibition of DNA gyrase/topoisomerase IV (fluoroquinolones).